AstraZeneca's silence has cost shareholders a record 240 billion kronor, equivalent to the entire Industrivärden, and it is urgent that the stock market is informed that no deal will be carried out as soon as possible. (translated)
AstraZeneca and Bristol Myers Squibb are in talks for a possible merger that could create a pharmaceutical giant valued at around 350 billion euros, although the negotiations could be delayed or may not come to fruition, according to the Financial Times. (translated)
AstraZeneca is considering merging with the American company Bristol Myers Squibb, which would create one of the largest pharmaceutical deals in history and elevate the combined entity among the four largest drug manufacturers in the world, although negotiations are still in the early stages and may face regulatory hurdles. (translated)
AstraZeneca and Bristol Myers are in negotiations to merge and create a pharmaceutical giant valued at approximately $400 billion, which has caused declines in AstraZeneca's shares and an increase in Bristol Myers'. (translated)
AstraZeneca is in negotiations with Bristol Myers Squibb for a possible merger valued at 348 billion euros, which would become one of the largest deals in the history of the pharmaceutical sector, expanding AstraZeneca's presence in the North American market. (translated)
The pharmaceutical companies AstraZeneca and Bristol Myers Squibb are negotiating a merger valued at 348 billion euros, which, if finalized, would create the fourth largest company in the pharmaceutical sector worldwide. (translated)
AstraZeneca is discussing a $400 billion merger with Bristol Myers Squibb, which could create the fourth global giant in the pharmaceutical sector, although there are risks of delays or failures in the negotiations. (translated)
The British pharmaceutical company AstraZeneca is in talks to merge with its American rival Bristol Myers Squibb, which would create one of the largest pharmaceutical groups in the world with a value approaching 400 billion dollars, but negotiations may be delayed or completely terminated. (translated)
AstraZeneca envisions a $400 billion merger with Bristol-Myers Squibb, benefiting from the complementarity of their portfolios focused respectively on cancer treatment and rare diseases, and on immunotherapy. (translated)
Astra Zeneca is in talks about a potential merger with American Bristol Myers Squibb which, if it goes through, would create one of the world's largest pharmaceutical companies valued at around 400 billion dollars, but the deal may face political and regulatory challenges. (translated)
O Ministério da Saúde concluiu em outubro de 2021 que o óbito de Bruno Graf foi causado pela "vacina" da Astrazeneca. Mas as autoridades só liberaram essa informação depois de anos, quando os advogados exigiram o relatório da conclusão da análise: A1, causalidade comprovada https://t.co/Q6c4d0Hbmh #Vacina #Astrazeneca #Saúde
Dr Soraya Bekkali z Alexion, AstraZeneca Rare Disease podkreśla, że do 2030 roku znaczna część terapii będzie dotyczyć chorób rzadkich, a dzięki regulacjom i politykom stworzonym w Europie, oraz niedawnej rezolucji WHO, zagadnienie to zyskuje na znaczeniu globalnym, co daje nadzieję na poprawę jakości diagnostyki i dostępu do leczenia dla pacjentów na całym świecie. #ChorobyRzadkie #AstraZeneca #Zdrowie
A moim zdaniem AstraZeneca (podobnie jak inni) powinna płacić w Polsce podatek przychodowy w wysokości 1,5-2%. I oczekuję od rządzących jasnej strategii w tej sprawie. Już ponad 30 lat jej oczekuję😀 Ale rządzący wolą podnosić Wam składki zdrowotne #AstraZeneca #Podatki #Polska
According to Wiktor Janicki, the president of AstraZeneca in Poland, if our country wants to have free access to modern therapies and diagnostics, the health contribution should increase to 13 percent. The company plans to continue investing here, but expects a clear strategy from the government. (translated)
Astra Zeneca har ingått ett exklusivt globalt licensavtal med Dizal Pharmaceutical för sin lungcancermedicin Zegfrovy (sunvozertinib), en oral EGFR-hämmare. #AstraZeneca #lungcancer #EGFRhæmmare
Astra Zenecas aktie föll kraftigt på torsdagen, vilket resulterade i förluster på hundratals miljarder kronor för bolagets aktieägare och gjorde det till en av de största dagliga kollapserna i Stockholmsbörsens historia, vilket väcker frågor om det kan vara ett tillfälle för bottenfiske. #AstraZeneca #aktiekollaps #börs
AstraZeneca ha adquirido los derechos globales, excluyendo Asia, de un nuevo fármaco pulmonar experimental llamado TQC3721 de la farmacéutica china Sino Biopharmaceutical por hasta 1.900 millones de dólares, con el objetivo de mejorar la función pulmonar en pacientes con afecciones respiratorias crónicas severas. #AstraZeneca #Farmacéutica #SaludPulmonar
A Astrazeneca le pagamos 53 millones de dólares por vacunas que nunca llegaron. A Sinopharm le pagamos una vacuna 16 dólares más caros que a la Pfizer. Algunas de las cosas que aún no tienen castigo. Link a la nota entera en el tuit que sigue. Adelanto: https://t.co/t3qRfT57lF #Vacunas #Salud #Corrupción
Astra Zeneca har gått med på att betala 34 miljoner dollar, motsvarande 330 miljoner kronor, som en förlikning efter bedrägerianklagelser i USA. #AstraZeneca #bedrägerianklagelser #förlikning
